Rebuttal to CHOP re: Fetal Cells

On July 11, 2019, the Children’s Hospital of Philadelphia (CHOP) published an article about fetal cells. Informed Choice WA reached out to Dr. Theresa Deisher, the PhD genetic engineer who discovered adult stem cells, for a fact check of CHOPs statements.

Many thanks to Dr. Deisher and Thu Pham for this detailed and informative rebuttal to CHOPs article, shown in boxes within the article. Please share this widely. You will find live links to references at the bottom of this page.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [1.04 MB]

Full 9 hours of testimony:


Link to citations in the above “Rebuttal to CHOP re: Fetal Cells” with much thanks to an advocate who took the time to locate them: (“Vaccine Excipient & Media Summary: Excipients Included in U.S. Vaccines, by Vaccine”) (Varivax package insert) package insert) (Victoria et al., “Viral nucleic acids in live-attnuated vaccines: detection of minority variants and an adventitious virus”) (Verbatim: Proceedings of the Matthew Bulfin Educational Conference, Houston, Texas, February 20-21, 2016) (Kissling et al., “Production of specific varicella antiserum”) (Best et al., “New Japanese rubella vaccine: comparative trials”) (Sound Choice publication on autism diagnosis and vaccines) (Stanley Plotkin: Pioneering the use of fetal cells to make rubella vaccine) (Ochs, “H1N1 vaccine-production method faulted”) (Mikovits, et al., “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome”) (Benedictus & C R Bell, “The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia”) (KING OF VACCINES COMES CLEAN! – PLOTKIN ON VACCINE | Del Bigtree HighWireTalk) (Stanley Plotkin: Pioneering the use of fetal cells to make rubella vaccine) (“Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis,” Lo et al. Am J Hum Genet. 1998 Apr;62(4):768-75) (“Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics,” Enninga et al. Front Immunol. 2015 Aug 26;6:424) (“Epidemiologic and Molecular Relationship Between Vaccine Manufacture and Autism Spectrum Disorder Prevalence,” Deisher et al. Issues Law Med. 2015 Spring;30(1):47-70) (NeoCutis statement to Washington Times re aborted fetal cell line in skin products) (How to purchase NeoCutis Skin Cream) (“Religious Concerns,” Immunization Action Coalition) (Sound Choice Pharmaceutical Institute) (USA & CANADA – ABORTED FETAL CELL LINE PRODUCTS AND ETHICAL ALTERNATIVES, Feb 2018)